Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
At least 40 villagers shot dead in latest violence in Nigeria's conflict
ABUJA, Nigeria (AP) — Armed men attacked remote villages in northcentral Nigeria, killing at least a2024-05-22A suspected Islamic State group attack on pro
BEIRUT (AP) — Suspected members of the Islamic State group attacked three posts for Syrian governmen2024-05-22Leipzig draws at Hoffenheim in Bundesliga
HOFFENHEIM, Germany (AP) — Hoffenheim scored in the last minute to draw with Leipzig 1-1 in the Bund2024-05-22Soccer fan arrested in Marseille as authorities investigate reports of Nazi salute, monkey chants
MARSEILLE, France (AP) — A soccer fan has been arrested by French police as local authorities invest2024-05-22Massey, Perez hit homers to lead Royals in 8
KANSAS CITY, Mo. (AP) — Michael Massey and Salvador Perez homered as the Kansas City Royals beat the2024-05-22Southern Brazil has been hit by the worst floods in 80 years. At least 37 people have died
SAO PAULO (AP) — Heavy rains in the southern Brazilian state of Rio Grande do Sul killed 37 people,2024-05-22
atest comment